ClinicalTrials.gov
public full text
Public Domain
A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
Angiopoietin-2 (Ang-2) is a protein in the body which destabilizes blood vessels and is important in stimulating tumor blood vessels. There is evidence suggesting that Ang-2 may be important for the growth and progression of Glioblastoma multiforme (GBM). PF- 04856884 (CVX-060) is a compound which binds Ang-2 and prevents its activity. The hypothesis is that PF-04856884 will be safe and effective in patients with recurrent Glioblastoma multiforme (GBM).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)#969886
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma#1139304
- Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma#842962
- Combination Therapy for the Treatment of Diffuse Midline Gliomas#1127068
- INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas#913417
Record · ID 1283009
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive